Radius Health, which is testing injectable and microneedle patch versions of its lead osteoporosis drug, filed plans Feb. 6 to dive into the public markets. The IPO is ambitious for life sciences ...

It was only a few days ago that Radius Health came out with Tymlos, a new competitor to Eli Lilly osteoporosis medication Forteo. And one prominent cost watchdog already has something to say about it.

This study extends the literature that uses in HR pQCT to examine ''bone quality" in vivo in a novel way using customized image acquisition and analyses protocols to assess bone parameters in the ...

This precision study was conducted in a medical imaging research centre setting and received academic institutional ethical approval from the University of British Columbia, Vancouver Canada.